Clinical Trials Register

Trials with a EudraCT protocol (108)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

108 result(s) found for: Gallbladder disease. Displaying page 1 of 6.

EudraCT Number: 2008-005135-15

Sponsor Protocol Number: 8101 colloidAug08

Start Date*: 2009-01-12

Sponsor Name:University of Nottingham

Full Title: Do 100 kiloDaltons matter? A prospective randomised double-blind study on the blood volume expanding effects of two different colloids in patients undergoing laparoscopic cholecystectomy

Medical condition: Patients undergoing laparoscopic cholecystectomy

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10006990	Calculus gallbladder	LLT
	9.1		10017626	Gallbladder disorder	LLT
	9.1		10006992	Calculus in gallbladder	LLT
	9.1		10042140	Stone in gallbladder	LLT
	9.1		10029543	Non-functioning gallbladder	LLT
	9.1		10003643	Atonic gallbladder	LLT
	9.1		10017633	Gallbladder inflammation	LLT
	9.1		10058468	Laparoscopic surgery	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2017-001538-25

Sponsor Protocol Number: AIO-HEP-0117

Start Date*: 2018-03-12

Sponsor Name:AIO-Studien-gGmbH

Full Title: A randomized phase II trial of durvalumab and tremelimumab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with cholangio- and gallbl...

Medical condition: advanced, unresectable and/or metastatic cholangio- and gallbladder carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004864	10017617	Gallbladder cancer non-resectable	LLT
	20.0	100000004864	10017620	Gallbladder carcinoma	LLT
	20.0	100000004864	10025941	Malignant neoplasm of gallbladder and extrahepatic bile ducts	LLT
	21.1	100000004864	10025940	Malignant neoplasm of gallbladder	LLT
	20.0	100000004864	10007426	Carcinoma of gallbladder	LLT
	21.1	100000004864	10017622	Gallbladder carcinoma non-resectable	LLT
	21.1	100000004864	10025943	Malignant neoplasm of gallbladder and extrahepatic bile ducts non-resectable	LLT
	21.1	100000004864	10077744	Adenocarcinoma of gallbladder metastatic	LLT
	21.1	100000004864	10077847	Gallbladder adenocarcinoma metastatic	LLT
	20.0	100000004864	10008594	Cholangiocarcinoma non-resectable	LLT
	21.1	100000004864	10077846	Cholangiocarcinoma metastatic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2007-000271-42

Sponsor Protocol Number: 11012007

Start Date*: 2007-05-08

Sponsor Name:Matti Eskelinen

Full Title: OKSIKODONIN ANALGEETTINEN PITOISUUS PLASMASSA YHDESSÄ PARASETAMOLIN 1g TAI 2g IV KANSSA ANNETTUNA MAHAKIRURGISILLA POTILAILLA

Medical condition: Tutkimukseen otetaan 24 sappileikkaukseen tulevaa perustervettä aikuispotilasta.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10017641	Gallbladder disease	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: FI (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004316-23

Sponsor Protocol Number: CLOMG

Start Date*: 2004-11-12

Sponsor Name:OSPEDALE S. RAFFAELE

Full Title: Randomised, controlled , double blind trial on emodinamic, analgesic, pharmacoeconomic effects of clonidine and magnesium in premedication of laparoscopic surgery for colecitis ablation.

Medical condition: Post operative analgesia.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	6.1		10017628		HLGT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2013-001364-30

Sponsor Protocol Number: BBH-TQL-LC

Start Date*: 2013-07-22

Sponsor Name:Bispebjerg Hospital

Full Title: Ultrasoundguided transmuscular quadrates lumborum block after elective laparoscopic cholecystectomy. A prospective, randomised clinical trial.

Medical condition: Postoperative pain following laparoscopic cholecystectomy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	16.1	100000004871	10049890	Cholecystolithiasis	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2012-001705-24

Sponsor Protocol Number: HE37/12

Start Date*: 2013-02-20

Sponsor Name:Hellenic Cooperative Oncology Group

Full Title: Phase II single-arm study of first line treatment with gemcitabine and pazopanib in patients with inoperable locally advanced or metastatic biliary tree cancer (cholangiocarcinoma or gallbladder ca...

Medical condition: Inoperable locally advanced or metastatic cancer of the biliary tree (cholangiocarcinoma and gallbladder carcinoma)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	100000004864	10017620	Gallbladder carcinoma	LLT
	14.1	100000004864	10008593	Cholangiocarcinoma	LLT
	14.1	100000004864	10004655	Biliary carcinoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GR (Prematurely Ended)

Trial results: View results

EudraCT Number: 2010-018850-11

Sponsor Protocol Number: MHH_CCA_AG54

Start Date*: 2011-04-15

Sponsor Name:Medizinische Hochschule Hannover (MHH)

Full Title: Panitumumab in combination with cisplatin/gemcitabine chemotherapy in patients with cholangiocarcinomas - a randomized clinical phase II study - PiCCA Study

Medical condition: cholangiocarcinoma / gall bladder carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	15.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017620	Gallbladder carcinoma	LLT
	15.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008593	Cholangiocarcinoma	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2012-005078-70

Sponsor Protocol Number: ACTICCA-1

Start Date*: 2014-01-16

Sponsor Name:University Medical Center Hamburg-Eppendorf

Full Title: Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) ...

Medical condition: Cholangiocarcinoma and gallbladder carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017620	Gallbladder carcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008593	Cholangiocarcinoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned) NL (Trial now transitioned) GB (GB - no longer in EU/EEA) DK (Completed) AT (Trial now transitioned) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2011-004878-29

Sponsor Protocol Number: NA

Start Date*: Information not available in EudraCT

Sponsor Name:St. Antonius Hospital

Full Title: Perioperative antibiotic use in the treatment of acute calculous cholecystitis

Medical condition: Acute calculous cholecystitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10019805 - Hepatobiliary disorders	10008612	Cholecystitis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2017-004444-38

Sponsor Protocol Number: GAIN/GEM/CIS

Start Date*: 2019-01-11

Sponsor Name:Krankenhaus Nordwest gGmbH

Full Title: Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally det...

Medical condition: incidental gallbladder carcinoma (IGBC) or biliary tract cancer (BTC) (intrahepatic cholangiocarcinoma (ICC)/ extrahepatic cholangiocarcinoma (ECC))

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025734	Malignant neoplasm of biliary tract, part unspecified	LLT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008593	Cholangiocarcinoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10028982	Neoplasm biliary tract	LLT
	20.0	10042613 - Surgical and medical procedures	10004675	Biliary tract and gallbladder therapeutic procedures	HLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017614	Gallbladder cancer	PT
	21.1	10042613 - Surgical and medical procedures	10061962	Gallbladder operation	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) AT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2021-000179-36

Sponsor Protocol Number: MS200647_0054

Start Date*: 2021-10-15

Sponsor Name:Merck KGaA

Full Title: An Open-label, Multicenter Follow-up Study to Collect Long-term Data on Participants from Multiple Bintrafusp alfa (M7824) Clinical Studies

Medical condition: Non-small cell lung cancer (NSCLC), biliary tract cancer (BTC), cervical cancer, and triple-negative breast cancer (TNBC)

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10073077	Intrahepatic cholangiocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10074879	Extrahepatic cholangiocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017614	Gallbladder cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008229	Cervical cancer	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10075566	Triple negative breast cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing) BE (Completed) ES (Ongoing) IT (Completed) DE (Completed)

Trial results: (No results available)

EudraCT Number: 2007-000043-10

Sponsor Protocol Number: 200701

Start Date*: 2007-01-30

Sponsor Name:Fakultní nemocnice Královské Vinohrady

Full Title: Combination of alpha2-adrenoreceptor agonists, opioids and ketamine for improving of perioperative course

Medical condition: Praeanaesthetic preparation (premedication) for patients scheduled for laparoscopic cholecystectomy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10008611	Cholecystectomy	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2021-002389-41

Sponsor Protocol Number: ADJUBIL

Start Date*: 2022-02-25

Sponsor Name:Frankfurter Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest

Full Title: A Phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer

Medical condition: biliary tract cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008593	Cholangiocarcinoma	PT
	20.0	10042613 - Surgical and medical procedures	10004675	Biliary tract and gallbladder therapeutic procedures	HLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10048798	Biliary adenoma	PT
	21.1	10042613 - Surgical and medical procedures	10061696	Biliary tract operation	PT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10073077	Intrahepatic cholangiocarcinoma	LLT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10074878	Hilar cholangiocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017620	Gallbladder carcinoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2016-000084-16

Sponsor Protocol Number: NC-6004-004A

Start Date*: 2016-11-24

Sponsor Name:NanoCarrier Co, Ltd

Full Title: A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine in Patients with Advanced Solid Tumors or Squamous Non-Small Cell Lung, Biliary Tract, and Blad...

Medical condition: Advanced solid tumors and first-line metastatic squamous NSCLC; first-line metastatic or locally advanced cholangiocarcinoma, gallbladder cancer, or ampullary cancer (biliary tract cancer); and fir...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10005003	Bladder cancer	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017614	Gallbladder cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BG (Completed) PL (Completed) IT (Completed)

Trial results: (No results available)

EudraCT Number: 2019-001992-35

Sponsor Protocol Number: MS200647_0055

Start Date*: 2020-04-30

Sponsor Name:Merck Healthcare KGaA

Full Title: A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp alfa (M7824) as First-line Treatment of Biliary Tract Cancer

Medical condition: Biliary Tract Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10028982	Neoplasm biliary tract	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10073077	Intrahepatic cholangiocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10074879	Extrahepatic cholangiocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017614	Gallbladder cancer	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10034442	Periampullary carcinoma metastatic	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10034443	Periampullary carcinoma non-resectable	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10034445	Periampullary carcinoma recurrent	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) FR (Prematurely Ended) PL (Completed) ES (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2020-004873-29

Sponsor Protocol Number: SGNTUC-019

Start Date*: 2021-05-31

Sponsor Name:Seagen Inc.

Full Title: A Phase 2 Basket Study of Tucatinib in Combination with Trastuzumab in Subjects with Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations

Medical condition: Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations

Disease:	Version	SOC Term	Classification Code	Term	Level
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008593	Cholangiocarcinoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017614	Gallbladder cancer	PT
	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025697	Malignant neoplasm of ampulla of Vater	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10064467	Urothelial carcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006187	Breast cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008342	Cervix carcinoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10046766	Uterine cancer	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Trial now transitioned) NL (Ongoing) DE (Trial now transitioned) PL (Completed) IT (Completed)

Trial results: (No results available)

EudraCT Number: 2009-018247-24

Sponsor Protocol Number: AR HSG 01 2010 cholecysthectomy

Start Date*: 2010-03-04

Sponsor Name:AZIENDA OSPEDALIERA SAN GERARDO DI MONZA

Full Title: Peritoneal nebulization of Ropivacaine for postoperative pain control after laparoscopic cholecystectomy A multicentre, randomized, controlled, double blinded, phase III clinical trial; comparing...

Medical condition: Elective Laparoscopic cholecystectomy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10008611	Cholecystectomy	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-003707-19

Sponsor Protocol Number: MS200647_0047

Start Date*: 2019-04-15

Sponsor Name:Merck KGaA

Full Title: A Phase II, Multicenter, Open label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or are Intolera...

Medical condition: Biliary Tract Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10028982	Neoplasm biliary tract	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10073077	Intrahepatic cholangiocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10074879	Extrahepatic cholangiocarcinoma	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017614	Gallbladder cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) IT (Completed)

Trial results: View results

EudraCT Number: 2010-021240-18

Sponsor Protocol Number: ARHSG062010

Start Date*: 2011-04-19

Sponsor Name:AZIENDA OSPEDALIERA S. GERARDO DI MONZA

Full Title: Peritoneal nebulization of Ropivacaine for pain control after laparoscopic colectomy

Medical condition: Elective Laparoscopic colectomy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10019805 - Hepatobiliary disorders	10017633	Gallbladder inflammation	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2014-002382-30

Sponsor Protocol Number: RDD677

Start Date*: 2015-03-13

Sponsor Name:The Clatterbridge Cancer Centre NHS Foundation Trust

Full Title: Phase II study of neoadjuvant cisplatin and gemcitabine chemotherapy versus upfront surgery in patients with resectable proximal biliary tract cancer:

Medical condition: Resectable Biliary Tract Carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017621	Gallbladder carcinoma localized	LLT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008593	Cholangiocarcinoma	PT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10034446	Periampullary carcinoma resectable	LLT

Population Age:

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Gallbladder disease